The experience of physicians in pharmacogenomic clinical decision support within eight German university hospitals.

AIM The aim of this study was to assess the physicians' attitude, their knowledge and their experience in pharmacogenomic clinical decision support in German hospitals. MATERIALS & METHODS We conducted an online survey to address physicians of 13 different medical specialties across eight German university hospitals. In total, 564 returned questionnaires were analyzed. RESULTS The remaining knowledge gap, the uncertainty of test reimbursement and the physicians' lack of awareness of existing pharmacogenomic clinical decision support systems (CDSS) are the major barriers for implementing pharmacogenomic CDSS into German hospitals. Furthermore, pharmacogenomic CDSS are most effective in the form of real-time decision support for internists. CONCLUSION Physicians in German hospitals require additional education of both genetics and pharmacogenomics. They need to be provided with access to relevant pharmacogenomic CDSS.

[1]  M. Peplow.  The 100 000 Genomes Project , 2016, British Medical Journal.

[2]  Muin J Khoury,et al.  Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. , 2011, American journal of preventive medicine.

[3]  Peter Tarczy-Hornoch,et al.  Usability evaluation of pharmacogenomics clinical decision support aids and clinical knowledge resources in a computerized provider order entry system: A mixed methods approach , 2014, Int. J. Medical Informatics.

[4]  R. Weinshilboum.  Inheritance and drug response. , 2003, The New England journal of medicine.

[5]  C. Schade-Brittinger,et al.  MIRACUM: Medical Informatics in Research and Care in University Medicine , 2018, Methods of information in medicine.

[6]  Rainu Kaushal,et al.  Effects of health information technology on patient outcomes: a systematic review , 2016, J. Am. Medical Informatics Assoc..

[7]  Meghan MacKenzie,et al.  Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review , 2017, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[8]  J. Brockmöller,et al.  Patients' and physicians' perspectives on pharmacogenetic testing. , 2006, Pharmacogenomics.

[9]  Russell L. Rothman,et al.  The ADAPTABLE Trial and PCORnet: Shining Light on a New Research Paradigm , 2015, Annals of Internal Medicine.

[10]  Karen Marder,et al.  Attitudes and Practices Among Internists Concerning Genetic Testing , 2013, Journal of Genetic Counseling.

[11]  K. J. Johansen Taber,et al.  Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties , 2014, Pharmacogenomics and personalized medicine.

[12]  Maryam Ahmadi,et al.  The effects of organizational contextual factors on physicians' attitude toward adoption of Electronic Medical Records , 2015, J. Biomed. Informatics.

[13]  Olivia R. Liu Sheng,et al.  Adoption of Telemedicine Technology by Health Care Organizations: An Exploratory Study , 2002, J. Organ. Comput. Electron. Commer..

[14]  Peter Tarczy-Hornoch,et al.  Development of clinical decision support alerts for pharmacogenomic incidental findings from exome sequencing , 2015, Genetics in Medicine.

[15]  José Antonio Miñarro-Giménez,et al.  An Ontology-Based, Mobile-Optimized System for Pharmacogenomic Decision Support at the Point-of-Care , 2014, PloS one.

[16]  P. Sankar,et al.  The Precision Medicine Initiative’s All of Us Research Program: an agenda for research on its ethical, legal, and social issues , 2016, Genetics in Medicine.

[17]  Michel Rousseau,et al.  Electronic health record acceptance by physicians: Testing an integrated theoretical model , 2014, J. Biomed. Informatics.

[18]  E. Clayton,et al.  Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT Project , 2012, Clinical pharmacology and therapeutics.

[19]  W Burke,et al.  Primary care physicians' knowledge of and experience with pharmacogenetic testing , 2012, Clinical genetics.

[20]  Mathieu Beaulieu,et al.  Systematic review of pharmacoeconomic studies of pharmacogenomic tests. , 2010, Pharmacogenomics.

[21]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2008, Journal of clinical epidemiology.

[22]  Megan Doerr,et al.  Cleveland Clinic's Center for personalized healthcare: setting the stage for value-based care. , 2014, Pharmacogenomics.

[23]  Manousos E. Kambouris,et al.  Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy , 2016, Public Health Genomics.

[24]  Teri E Klein,et al.  Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. , 2015, Annual review of pharmacology and toxicology.

[25]  R. Verbrugge,et al.  Adoption of Pharmacogenomic Testing by US Physicians: Results of a Nationwide Survey , 2012, Clinical pharmacology and therapeutics.

[26]  A. Viera,et al.  Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy. , 2012, Pharmacogenomics.

[27]  Cloann Schultz,et al.  Evaluation of the use of clinical decision support and online resources for pharmacogenomics education. , 2015, Pharmacogenomics.

[28]  Pamela E. Grimm.  Pretesting a Questionnaire , 2010 .

[29]  M. Relling,et al.  Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease , 2016, Pediatrics.

[30]  C. McBride,et al.  Too Many Referrals of Low-Risk Women for BRCA1/2 Genetic Services by Family Physicians , 2008, Cancer Epidemiology Biomarkers & Prevention.

[31]  M. Relling,et al.  Development and implementation of a pharmacist-managed clinical pharmacogenetics service. , 2011, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[32]  Jeffrey C. Hall,et al.  The CLIPMERGE PGx Program: Clinical Implementation of Personalized Medicine Through Electronic Health Records and Genomics–Pharmacogenomics , 2013, Clinical pharmacology and therapeutics.

[33]  B. Goff,et al.  Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians , 2011, Cancer.

[34]  Harry Hochheiser,et al.  Bringing clinical pharmacogenomics information to pharmacists: A qualitative study of information needs and resource requirements , 2016, Int. J. Medical Informatics.

[35]  Kevin B. Johnson,et al.  Electronic health record design and implementation for pharmacogenomics: a local perspective , 2013, Genetics in Medicine.

[36]  J. Hoffman,et al.  Integrating pharmacogenomics into electronic health records with clinical decision support. , 2016, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[37]  Casey Lynnette Overby,et al.  Making pharmacogenomic-based prescribing alerts more effective: A scenario-based pilot study with physicians , 2015, J. Biomed. Informatics.

[38]  Matthias Samwald,et al.  Examining perceptions of the usefulness and usability of a mobile-based system for pharmacogenomics clinical decision support: a mixed methods study , 2016, PeerJ.

[39]  E. McGlynn,et al.  Building Data Infrastructure to Evaluate and Improve Quality: PCORnet. , 2015, Journal of oncology practice.

[40]  Joseph L. Kannry,et al.  Physician Attitudes toward Adopting Genome-Guided Prescribing through Clinical Decision Support , 2014, Journal of personalized medicine.

[41]  Kristin A. Maloney,et al.  The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real‐World Implementation , 2013, Clinical pharmacology and therapeutics.

[42]  J. Peterson,et al.  Clinician Perspectives on Using Pharmacogenomics in Clinical Practice. , 2015, Personalized medicine.

[43]  T. Hurlimann,et al.  An evaluation of pharmacists' expectations towards pharmacogenomics. , 2013, Pharmacogenomics.